Medidata has partnered with integrated research organization Circuit Clinical to step up its decentralized clinical trial (DCT) offering.
Circuit Clinical, like other integrated research organizations, is focused on enabling patients to choose clinical research as a care option. Now, Circuit Clinical is investing to expand its DCT network to meet the rise in demand for decentralized trials.
“The COVID-19 pandemic has propelled interest in and adoption of DCTs. As the landscape of clinical trials has evolved, scalable, flexible, and intuitive solutions are necessary. The next era of clinical trials is underway, and the fuel for success will be improvements in patient, site, and sponsor experiences,” said Kelly McKee, vice president of patient registries and recruitment at Medidata.
Through the alliance, Circuit Clinical will standardize its DCT sites on Medidata’s RAVE and myMedidata technologies. Today, Circuit Clinical has a network of 90 doctors across more than 30 sites and is working to grow its operation.
Investors are supporting the expansion. With Medidata contributing to a $27m financing round, Circuit Clinical plans to expand its network to cover 500 physician investigators and 15m patients.
McKee foresees the use of Medidata technologies at Circuit Clinical sites resulting in faster study starts and improved patient recruitment while enabling optimization to any level of study decentralization.
“It is critical for patients, sponsors, and sites to have a single platform for all their clinical trial needs,” said McKee. “Implementing the right level of decentralization using an end-to-end, unified, and secure platform allows sponsors to improve chances of trial success, increase protocol adherence and safety monitoring, and bring value to patients, sites, and sponsors.”
Circuit Clinical will invite its participating healthcare systems to join myMedidata Clinical Trial Patient Registries. In doing so, the partners aim to raise awareness of, and access to, clinical trial opportunities.
Study subjects will have the opportunity to rate and review their experiences of participating in clinical trials using Circuit Clinical’s TrialJourney system. The partners are aiming to improve the experiences of patients and, in doing so, make it easier to retain patients. Today, Circuit Clinical claims a 93% retention rate across all projects.
Circuit Clinical’s current offering covers cardiovascular disease, diabetes, women’s health, kidney disease, digestive diseases, rheumatoid arthritis, cancer, COVID-19, and other therapeutic areas.
